Valuation: Kintor Pharmaceutical Limited

Market Cap 668M 783M 99.73M 89.09M 83.03M 75.28M 142M 9.47B 143M 995M 389M 4.92B 375M 366M 15.8B P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 721M 846M 108M 96.27M 89.73M 81.36M 153M 10.23B 154M 1.07B 421M 5.32B 405M 396M 17.07B EV / Sales 2024
75,794,130x
EV / Sales 2025 28,245,180x
Free-Float
88.01%
Yield 2024 *
-
Yield 2025 -
1 day-0.94%
1 week-8.91%
Current month-9.94%
1 month-17.45%
3 months-12.43%
6 months-43.99%
Current year-19.13%
1 week 1.54
Extreme 1.54
1.74
1 month 1.54
Extreme 1.54
2.09
Current year 1.54
Extreme 1.54
4.7
1 year 1.54
Extreme 1.54
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
64
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 2009-03-23
Director of Finance/CFO 48 2026-09-20
Chief Tech/Sci/R&D Officer 49 2020-08-31
Director TitleAgeSince
Director/Board Member 62 2019-08-11
Director/Board Member 61 2019-08-11
Chairman 64 2009-03-23
Date Insider Type Main position Quantity % Market Cap. Importance
7/17/26 Other

Chief Executive Officer

145,000 0.0291%
5/21/26 Other

Chief Executive Officer

38,000 0.0076%
5/18/26 Other

Chief Executive Officer

170,000 0.0341%
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%-8.91%-25.24%-42.78% 101M
-2.01%-7.86%+54.60%+70.97% 70.44B
+3.31%-11.47%+8.03%+57.96% 50.31B
+3.23%+1.46%+11.88%+37.43% 47.51B
+1.48%+2.32%+28.98%+32.73% 42.91B
+2.67%-4.17%+305.23%+464.14% 40.39B
+0.61%-3.78%+9.14%+101.37% 39.69B
-0.39%-1.48%+10.41%+43.19% 30.59B
-2.95%-12.28%+43.51%+1.51% 26.8B
-0.11%-6.55%-13.25%-8.21% 22.36B
Average +0.49%-6.05%+43.33%+75.83% 37.11B
Weighted average by Cap. +0.75%-5.39%+53.72%+94.43%

Financials

2024 2025
Net sales 5 5.86 0.75 0.67 0.62 0.56 1.06 70.9 1.07 7.45 2.92 36.88 2.81 2.74 118.33 32.68 38.32 4.88 4.36 4.07 3.69 6.94 463.46 6.99 48.7 19.06 241.03 18.34 17.93 773.45
Net income -155M -182M -23.2M -20.72M -19.32M -17.51M -32.96M -2.2B -33.22M -231M -90.59M -1.15B -87.13M -85.22M -3.68B -200M -235M -29.89M -26.71M -24.89M -22.57M -42.47M -2.84B -42.8M -298M -117M -1.48B -112M -110M -4.74B
Net Debt -15.68M -18.38M -2.34M -2.09M -1.95M -1.77M -3.33M -222M -3.35M -23.37M -9.15M -116M -8.8M -8.6M -371M 53.86M 63.15M 8.05M 7.19M 6.7M 6.07M 11.43M 764M 11.52M 80.26M 31.42M 397M 30.22M 29.56M 1.27B
Projected Income Statement - Annual - Kintor Pharmaceutical Limited
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
122
Date Price Change Volume
26-10-14 HK$1.585 -0.94% 722,500
26-10-13 HK$1.600 -4.76% 728,500
26-10-12 HK$1.680 +2.75% 866,000
26-10-09 HK$1.635 -0.91% 971,500
26-10-08 HK$1.650 -5.17% 1,239,500

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Kintor Pharmaceutical Limited
  1. Stock Market
  2. Stocks
  3. 9939 Stock